NATUREX : Dividend of EUR 0.11 per share voted by the Joint General Meeting. Option of payment in shares until September 30

le
0

Avignon, July 7, 2010 - The shareholders of Naturex met at the Group's Joint General Meeting in Paris on June 30, 2010. 

Following a brief presentation of the Group's current situation and the ongoing integration of the Ingredients division of Natraceutical, Jacques Dikansky submitted to a vote all nineteen resolutions adopted by present or represented shareholders.

Notably, the General Meeting overwhelmingly approved the resolution governing the payment of a dividend of ¤ 0.11 per share, a 10% increase on the previous year. For the first time, this dividend may be paid in new shares.

As such, shareholders will have the possibility - through their financial intermediary - of opting for payment of their dividend in shares within the option period (from July 7 through September 30, 2010). Once this deadline has expired, shareholders who have not exercised this option will receive their dividend payment in cash.

The share price will be ¤ 26.85, which corresponds to 90% of the average closing price of the twenty trading sessions preceding the General Meeting, minus the net dividend amount.

If the value of the dividend for which the option is exercised does not correspond to a whole number of shares, shareholders may:

- either obtain the whole number of shares immediately above the exact amount by paying the difference in cash;

- or receive the whole number of shares immediately below the exact amount in addition to receiving the remaining balance in cash.

The detachment date for the dividend is set at July 7. Payment and delivery of the shares will take place as of September 30, 2010.

Naturex will publish its H1 2010 revenue on July 27, 2010 after market close.

If you would like to receive financial information about Naturex by e-mail, go to: www.actusnews.com

NATUREX has been listed on segment B of Euronext Paris since October 1996.

Number of shares: 6,364,000 (4,843,597 ordinary shares and 1,520,403 preferential shares).

ISIN: FR0000054694 - Reuters: NATU.PA - Bloomberg: NRX:FP

www.naturex.com

 

About Naturex:

Naturex is the global leader in specialty plant-based natural ingredients. The company produces and markets natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries. The Group has three strategic divisions: Food & Beverage, Nutrition & Health and Personal Care.

Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers with the means to meet the requirements of their end consumers. Its strength lies in its ability to position itself on specific products which constitute niche markets.

Based in Avignon, the Group employs around 900 people and realizes over 90% of its sales overseas. Naturex has production units across Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has 15 sales offices located in Europe, the United States and Asia.

Naturex contacts:

Jacques Dikansky President and CEO, Tel. +33 (0)4 90 23 96 89, naturex@naturex.com

Thierry Lambert, Vice-President and CFO, Tel. +33 (0)4 90 23 96 89, t.lambert@naturex.com

Actus contacts:

Laurence Marquézy, Investor Relations, Tel. + 33 (0)1 72 74 82 23, lmarquezy@actus.fr

Anne Catherine Bonjour, Press Relations, Tel. + 33 (0)1 53 67 36 93, acbonjour@actus.fr

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-20500-naturex-070710-cp-post-ag-en.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant